SCHEMBL1009710

SCHEMBL1009710

CC(C)(C)c1ccc(Nc2ccc3c(c2)CCO3)cc1

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.52
KDM4E B2RXH2 1/20 0.52
NPC1 O15118 1/20 0.52
TRPV1 Q8NER1 8/20 0.46
PLK1 P53350 1/20 0.45
MEN1 O00255 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
MTOR P42345 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PKLR P30613 1/20 0.41
KIF11 P52732 1/20 0.41
PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL379048 0.85 PRKCI (0.50) MAPTNPC1PLK1RAB9ASMN1; SMN2
SCHEMBL1009963 0.83 TRPV1 (0.62) MAPTTRPV1MEN1TSHRMAPK1
SCHEMBL31172596 0.82 MAPT (0.57) MAPTKDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL799979 0.82 MAPT (0.57) MAPTKDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL12591823 0.80 MAPT (0.67) MAPTKDM4ENPC1TRPV1RAB9A
SCHEMBL11821584 0.78 PLK1 (0.51) MAPTKDM4ENPC1PLK1RAB9A
SCHEMBL1009863 0.75 KMT2A (0.44) MAPTNPC1PLK1MEN1RAB9A
SCHEMBL4005198 0.75 TRPV1 (0.78) MAPTTRPV1MEN1TSHRMAPK1
SCHEMBL4005191 0.75 TRPV1 (0.78) MAPTTRPV1MEN1TSHRMAPK1
SCHEMBL13676052 0.75 TRPV1 (0.78) MAPTNPC1TRPV1MEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1801189-B1 Synergistic lubricating oil composition containing a mixture of a benzo[b]perhydroheterocyclic arylamine and a diarylamine CHEVRON ORONITE CO (US) 2012-11-07 EP disclosed
EP-1801189-B1 Synergistic lubricating oil composition containing a mixture of a benzo[b]perhydroheterocyclic arylamine and a diarylamine CHEVRON ORONITE CO (US) 2012-11-07 EP disclosed
US-8003583-B2 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions CHEVRON ORONITE COMPANY LLC (US) 2011-08-23 US disclosed
US-8003583-B2 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions CHEVRON ORONITE COMPANY LLC (US) 2011-08-23 US disclosed
US-8003583-B2 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions CHEVRON ORONITE COMPANY LLC (US) 2011-08-23 US disclosed
EP-1801104-B1 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions CHEVRON ORONITE CO (US) 2011-01-05 EP disclosed
EP-1801104-B1 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions CHEVRON ORONITE CO (US) 2011-01-05 EP disclosed
US-7501386-B2 Lubricants for automotive and truck crankcase lubricants; as well as transmission lubricants, gear lubricants, hydraulic fluids, compressor oils, diesel and marine lubricants; superior oxidation inhibition; Phenyl-(1,2,3,4-tetrahydro-quinolin-6-yl)-amine, diphenylamine CHEVRON ORONITE COMPANY, LLC (US) 2009-03-10 US disclosed
US-7501386-B2 Lubricants for automotive and truck crankcase lubricants; as well as transmission lubricants, gear lubricants, hydraulic fluids, compressor oils, diesel and marine lubricants; superior oxidation inhibition; Phenyl-(1,2,3,4-tetrahydro-quinolin-6-yl)-amine, diphenylamine CHEVRON ORONITE COMPANY, LLC (US) 2009-03-10 US disclosed
US-7501386-B2 Lubricants for automotive and truck crankcase lubricants; as well as transmission lubricants, gear lubricants, hydraulic fluids, compressor oils, diesel and marine lubricants; superior oxidation inhibition; Phenyl-(1,2,3,4-tetrahydro-quinolin-6-yl)-amine, diphenylamine CHEVRON ORONITE COMPANY, LLC (US) 2009-03-10 US disclosed
EP-1801104-A2 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions Chevron Oronite Company LLC (US) 2007-06-27 EP disclosed
EP-1801189-A2 Synergistic lubricating oil composition containing a mixture of a benzo[b]perhydroheterocyclic arylamine and a diarylamine Chevron Oronite Company LLC (US) 2007-06-27 EP disclosed
EP-1801189-A2 Synergistic lubricating oil composition containing a mixture of a benzo[b]perhydroheterocyclic arylamine and a diarylamine Chevron Oronite Company LLC (US) 2007-06-27 EP disclosed
US-20070142243-A1 Synergistic lubricating oil composition containing a mixture of a benzo[b]perhydroheterocyclic arylamine and a diarylamine CHEVRON ORONITE COMPANY LLC 2007-06-21 US disclosed
US-20070142243-A1 Synergistic lubricating oil composition containing a mixture of a benzo[b]perhydroheterocyclic arylamine and a diarylamine CHEVRON ORONITE COMPANY LLC 2007-06-21 US disclosed
US-20070142243-A1 Synergistic lubricating oil composition containing a mixture of a benzo[b]perhydroheterocyclic arylamine and a diarylamine CHEVRON ORONITE COMPANY LLC 2007-06-21 US disclosed
US-20070142246-A1 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions CHEVRON ORONITE COMPANY LLC 2007-06-21 US disclosed
US-20070142246-A1 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions CHEVRON ORONITE COMPANY LLC 2007-06-21 US disclosed
US-20070142246-A1 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions CHEVRON ORONITE COMPANY LLC 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142246-A1 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions AHR, ARNT, HRH2 MAPT 2668/4885KDM4E 3464/4885NPC1 1276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.